Lipoxin A4, CAS [[89663-86-5]]

Produktübersicht

• Artikelname: Lipoxin A4, CAS [[89663-86-5]]
• Artikelnummer: AMO-M30835
• Hersteller Artikelnummer: M30835
• Alternativnummer: AMO-M30835-25UG,AMO-M30835-50UG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien
• Alternative Synonym: LXA4

Produktbeschreibung

Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.

Produkteigenschaften

• Molekulargewicht: 352.47
• Reinheit: 98.0%
• CAS Nummer: [89663-86-5]
• Formel: C20H32O5
• Target-Kategorie: IL Receptor/Related